Apotex paid Sanofi and Bristol-Myers $445 million
Sanofi’s annual results have revealed that generic rival Apotex paid it and partner Bristol-Myers Squibb over $445 million to settle a dispute over blockbuster drug Plavix
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: